glp-1 in development A timeline of GLP- 1 discovery and clinical development. Created GLP-1 Receptor Agonist Market Size

Within the minimum time window This should go without saying, but do not inject within 48 hours (semaglutide) or 72 hours (tirzepatide) of your last dose under any circumstances

Cave advises: "Seek help for severe, persistent stomach pain radiating to the back, with nausea/vomiting." Differentiate from common GI side effects (mild nausea in 20-40% users)

To explore insured impacts further, and how they may translate to your policyholders, reach out to your local RGA representative

This study (STEP-1 trial) demonstrated that participants using semaglutide lost a significant amount of weight, with approximately 39% of the weight loss attributed to lean mass , raising concerns about muscle preservation during GLP-1-induced weight loss